Lin Patrick
Insider CIK 1799363 · PCSA Chief Business - Strategy Off
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-26 | 2026-07-28 | 8,450 | — | $0 | 11,389 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-26 | 2026-07-28 | 8,450 | — | $0 | 11,389 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-06-30 | 2026-07-01 | 2,106 | $1.93 | $4.1K | 13,113 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-06-15 | 2026-06-16 | 1,831 | $2.22 | $4.1K | 11,007 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-05-29 | 2026-06-01 | 1,582 | $2.57 | $4.1K | 9,176 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-05-15 | 2026-05-19 | 1,369 | $2.97 | $4.1K | 7,594 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-04-30 | 2026-05-01 | 1,511 | $2.69 | $4.1K | 6,236 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-04-15 | 2026-04-17 | 1,369 | $2.97 | $4.1K | 4,725 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2026-03-31 | 2026-04-01 | 1,603 | $2.54 | $4.1K | 3,356 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise deriv | 2026-01-01 | 2026-02-04 | 193 | — | $0 | 0 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2026-01-01 | 2026-02-04 | 193 | — | $0 | 1,753 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-03 | 68,000 | — | $0 | 68,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-03 | 204,000 | — | $0 | 204,000 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-07-24 | 2025-07-28 | 1,401,650 | — | $0 | 1,412,082 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2025-04-01 | 2025-04-11 | 4,814 | $0.41 | $2.0K | 38,727 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2025-04-01 | 2025-04-11 | 14,482 | — | $0 | 43,541 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-01-29 | 2025-02-18 | 43,500 | — | $0 | 43,500 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2025-01-29 | 2025-02-18 | 21,750 | — | $0 | 21,750 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2025-01-27 | 2025-01-29 | 43,500 | $0.80 | $34.8K | 43,500 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2024-07-10 | 2024-08-02 | 644 | — | $0 | 29,330 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2024-07-10 | 2024-08-02 | 271 | $1.71 | $463 | 29,059 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 2,713 | — | $0 | 22,201 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 339 | — | $0 | 24,914 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 2,035 | — | $0 | 24,236 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 339 | — | $0 | 24,575 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2024-04-05 | 2024-08-02 | 1,675 | — | $0 | 29,225 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2024-04-05 | 2024-08-02 | 539 | $2.79 | $1.5K | 28,686 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2024-02-01 | 2024-02-01 | 1,500 | $2.40 | $3.6K | 27,478 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2024-01-31 | 2024-02-01 | 2,500 | $2.37 | $5.9K | 25,978 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise deriv | 2024-01-01 | 2024-04-12 | 1,675 | — | $0 | 20,132 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2024-01-01 | 2024-04-12 | 1,675 | — | $0 | 29,153 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2024-01-01 | 2024-04-12 | 539 | $2.79 | $1.5K | 28,614 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-10-12 | 2023-10-12 | 5,000 | $0.32 | $1.6K | 469,535 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-10-10 | 2023-10-10 | 13,700 | $0.21 | $2.9K | 464,535 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-02-09 | 2023-02-10 | 12,500 | $0.80 | $10.0K | 450,835 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2023-01-01 | 2023-01-04 | 40,690 | — | $0 | 440,328 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2023-01-01 | 2023-01-04 | 55,107 | — | $0 | 399,638 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-12-31 | 2023-01-04 | 10,851 | — | $0 | 344,531 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-09-30 | 2022-10-03 | 10,850 | — | $0 | 333,680 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2022-08-05 | 2022-08-09 | 7,601 | — | $0 | 440,991 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2022-08-05 | 2022-08-09 | 2,656 | $3.17 | $8.4K | 438,335 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-06-30 | 2022-07-05 | 20,064 | — | $0 | 322,830 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2022-05-17 | 2022-05-19 | 2,000 | $1.59 | $3.2K | 433,390 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2022-04-07 | 2022-04-08 | 800 | $3.54 | $2.8K | 431,390 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2022-04-06 | 2022-04-08 | 1,200 | $3.13 | $3.8K | 430,590 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-04-01 | 2022-04-11 | 247,841 | — | $0 | 302,766 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-03-31 | 2022-04-04 | 10,715 | — | $0 | 37,781 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-12-31 | 2022-01-06 | 6,722 | — | $0 | 22,780 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2021-12-14 | 2022-01-04 | 3,000 | $4.00 | $12.0K | 429,390 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2021-12-14 | 2021-12-16 | 3,000 | $4.00 | $12.0K | 429,390 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2021-12-03 | 2021-12-07 | 3,500 | $4.80 | $16.8K | 426,390 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-11-01 | 2022-04-04 | 4,286 | — | $0 | 27,066 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-09-30 | 2022-01-06 | 6,024 | — | $0 | 16,058 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-09-30 | 2021-10-04 | 6,024 | — | $0 | 6,024 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2021-08-26 | 2021-08-30 | 4,000 | $6.02 | $24.1K | 422,890 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2021-08-05 | 2021-08-09 | 7,601 | — | $0 | 418,890 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-07-08 | 2021-07-09 | 8,572 | — | $0 | 8,572 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-07-08 | 2021-07-09 | 1,907 | — | $0 | 10,034 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-07-08 | 2021-07-09 | 12,858 | — | $0 | 12,858 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2021-06-21 | 2021-06-22 | 2,000 | $6.65 | $13.3K | 401,737 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-06-08 | 2021-06-10 | 8,127 | — | $0 | 8,127 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2020-10-01 | 2020-10-05 | 31,250 | $2.10 | $65.6K | 399,737 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2020-10-01 | 2020-10-05 | 31,250 | $4.00 | $125.0K | 399,737 | SEC↗ |